Literature DB >> 19148749

Wnt/beta-catenin/Tcf signaling pathway activation in malignant progression of rat gliomas induced by transplacental N-ethyl-N-nitrosourea exposure.

Gangadhara Reddy Sareddy1, Sundaram Challa, Manas Panigrahi, Phanithi Prakash Babu.   

Abstract

Although Wnt/beta-catenin/Tcf signaling pathway has been shown to be a crucial factor in the development of many cancers, little is known about its role in glioma malignancy. In the present study, we report the first evidence that Wnt/beta-catenin/Tcf signaling pathway is constitutively activated in experimental gliomas induced by single transplacental dose of N-ethyl-N-nitrosourea (ENU). In the present study we analyzed ENU induced rat gliomas of different stages (P90, P135 and P180) for the expression of beta-catenin, Lef1, Tcf4 and their targets c-Myc, N-Myc and cyclin D1. Western blot analysis revealed upregulation of beta-catenin, Lef1, Tcf4, c-Myc, N-Myc and cyclin D1 in gliomas compared to controls and their levels were progressively increased from initial stage (P90) to progression stage (P180). In consistent with this, immunohistochemistry revealed the cytoplasmic and nuclear accumulation of beta-catenin, and nuclear positivity was evident for Lef1, Tcf4, c-Myc, N-Myc and cyclin D1. Based on these results, we conclude that Wnt/beta-catenin pathway may play a major role in the tumorigenesis and tumor progression in ENU induced rat gliomas.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19148749     DOI: 10.1007/s11064-008-9906-3

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  47 in total

Review 1.  Mechanisms of Wnt signaling in development.

Authors:  A Wodarz; R Nusse
Journal:  Annu Rev Cell Dev Biol       Date:  1998       Impact factor: 13.827

Review 2.  Commentary: is the concept of "tumor promotion" a useful paradigm?

Authors:  J E Trosko
Journal:  Mol Carcinog       Date:  2001-03       Impact factor: 4.784

3.  Quantitative aspects of transplacental tumor induction with ethylnitrosourea in rats.

Authors:  J A Swenberg; A Koestner; W Wechsler; R H Denlinger
Journal:  Cancer Res       Date:  1972-12       Impact factor: 12.701

4.  Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme.

Authors:  Y Hayashi; K Ueki; A Waha; O D Wiestler; D N Louis; A von Deimling
Journal:  Brain Pathol       Date:  1997-07       Impact factor: 6.508

5.  Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients.

Authors:  M L Simmons; K R Lamborn; M Takahashi; P Chen; M A Israel; M S Berger; T Godfrey; J Nigro; M Prados; S Chang; F G Barker; K Aldape
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

6.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

Review 7.  Genetic pathways to primary and secondary glioblastoma.

Authors:  Hiroko Ohgaki; Paul Kleihues
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

Review 8.  Caught up in a Wnt storm: Wnt signaling in cancer.

Authors:  Rachel H Giles; Johan H van Es; Hans Clevers
Journal:  Biochim Biophys Acta       Date:  2003-06-05

Review 9.  WNT and beta-catenin signalling: diseases and therapies.

Authors:  Randall T Moon; Aimee D Kohn; Giancarlo V De Ferrari; Ajamete Kaykas
Journal:  Nat Rev Genet       Date:  2004-09       Impact factor: 53.242

Review 10.  Chemical induction of brain tumors in rats by nitrosoureas: molecular biology and neuropathology.

Authors:  T Bilzer; G Reifenberger; W Wechsler
Journal:  Neurotoxicol Teratol       Date:  1989 Nov-Dec       Impact factor: 3.763

View more
  22 in total

1.  Nonsteroidal anti-inflammatory drugs diclofenac and celecoxib attenuates Wnt/β-catenin/Tcf signaling pathway in human glioblastoma cells.

Authors:  Gangadhara Reddy Sareddy; Divya Kesanakurti; Puligurtha Bharadhwaja Kirti; Phanithi Prakash Babu
Journal:  Neurochem Res       Date:  2013-09-08       Impact factor: 3.996

2.  The role of Pygopus 2 in rat glioma cell growth.

Authors:  Yu-Ying Chen; Bo-An Li; Hai-Dong Wang; Xi-Yao Liu; Guo-Wei Tan; Yong-Hui Ma; Shang-Hang Shen; Hong-Wei Zhu; Zhan-Xiang Wang
Journal:  Med Oncol       Date:  2010-04-02       Impact factor: 3.064

3.  Increased β-catenin/Tcf signaling in pilocytic astrocytomas: a comparative study to distinguish pilocytic astrocytomas from low-grade diffuse astrocytomas.

Authors:  Gangadhara Reddy Sareddy; Khamushavalli Geeviman; Manas Panigrahi; Sundaram Challa; Anita Mahadevan; Phanithi Prakash Babu
Journal:  Neurochem Res       Date:  2011-09-16       Impact factor: 3.996

Review 4.  Current Understanding on EGFR and Wnt/β-Catenin Signaling in Glioma and Their Possible Crosstalk.

Authors:  Indranil Paul; Seemana Bhattacharya; Anirban Chatterjee; Mrinal K Ghosh
Journal:  Genes Cancer       Date:  2013-11

5.  Downregulation of Pygopus 2 inhibits vascular mimicry in glioma U251 cells by suppressing the canonical Wnt signaling pathway.

Authors:  Haidong Wang; Jianhua Fu; Dianshuang Xu; Weiwei Xu; Shiyong Wang; Liu Zhang; Yongsheng Xiang
Journal:  Oncol Lett       Date:  2015-11-13       Impact factor: 2.967

6.  β-Catenin signaling initiates the activation of astrocytes and its dysregulation contributes to the pathogenesis of astrocytomas.

Authors:  Chunzhang Yang; Rajiv R Iyer; Albert C H Yu; Raymund L Yong; Deric M Park; Robert J Weil; Barbara Ikejiri; Roscoe O Brady; Russell R Lonser; Zhengping Zhuang
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-13       Impact factor: 11.205

7.  Decreased pygopus 2 expression suppresses glioblastoma U251 cell growth.

Authors:  Zhan-Xiang Wang; Yu-Ying Chen; Bo-An Li; Guo-Wei Tan; Xi-Yao Liu; Shang-Hang Shen; Hong-Wei Zhu; Hai-Dong Wang
Journal:  J Neurooncol       Date:  2010-03-05       Impact factor: 4.130

8.  β-Catenin overexpression in malignant glioma and its role in proliferation and apoptosis in glioblastma cells.

Authors:  Xiangrong Liu; Lei Wang; Shangfeng Zhao; Xunming Ji; Yumin Luo; Feng Ling
Journal:  Med Oncol       Date:  2010-03-19       Impact factor: 3.064

9.  Expression and aberrant promoter methylation of Wnt inhibitory factor-1 in human astrocytomas.

Authors:  Zhuanyi Yang; Ying Wang; Jiasheng Fang; Fenghua Chen; Jinfang Liu; Jun Wu; Yanjin Wang
Journal:  J Exp Clin Cancer Res       Date:  2010-03-24

10.  Differentiation of the brain vasculature: the answer came blowing by the Wnt.

Authors:  Stefan Liebner; Karl H Plate
Journal:  J Angiogenes Res       Date:  2010-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.